- Home
- XMTR vs CPRX Comparison
XMTR vs CPRX Comparison
Compare XMTR & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XMTR
- CPRX
- Stock Information
- Founded
- XMTR 2013
- CPRX 2002
- Country
- XMTR United States
- CPRX United States
- Employees
- XMTR N/A
- CPRX N/A
- Industry
- XMTR Industrial Machinery/Components
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- XMTR Technology
- CPRX Health Care
- Exchange
- XMTR Nasdaq
- CPRX Nasdaq
- Market Cap
- XMTR 2.4B
- CPRX 2.6B
- IPO Year
- XMTR 2021
- CPRX 2006
- Fundamental
- Price
- XMTR $47.68
- CPRX $20.23
- Analyst Decision
- XMTR Buy
- CPRX Strong Buy
- Analyst Count
- XMTR 11
- CPRX 5
- Target Price
- XMTR $37.00
- CPRX $33.20
- AVG Volume (30 Days)
- XMTR 1.0M
- CPRX 1.5M
- Earning Date
- XMTR 08-05-2025
- CPRX 08-06-2025
- Dividend Yield
- XMTR N/A
- CPRX N/A
- EPS Growth
- XMTR N/A
- CPRX 183.96
- EPS
- XMTR N/A
- CPRX 1.65
- Revenue
- XMTR $603,762,000.00
- CPRX $558,499,000.00
- Revenue This Year
- XMTR $21.50
- CPRX $16.37
- Revenue Next Year
- XMTR $17.08
- CPRX $8.80
- P/E Ratio
- XMTR N/A
- CPRX $12.27
- Revenue Growth
- XMTR 20.19
- CPRX 28.55
- 52 Week Low
- XMTR $16.11
- CPRX $19.00
- 52 Week High
- XMTR $48.60
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- XMTR 71.97
- CPRX 42.27
- Support Level
- XMTR $41.23
- CPRX $19.82
- Resistance Level
- XMTR $48.60
- CPRX $20.51
- Average True Range (ATR)
- XMTR 2.95
- CPRX 0.72
- MACD
- XMTR 1.26
- CPRX -0.04
- Stochastic Oscillator
- XMTR 94.88
- CPRX 31.95
About XMTR Xometry Inc.
Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of its revenue is derived from the U.S. segment.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).